Last reviewed · How we verify
Bacterial pyelonephritis
Approved treatments
- Zerbaxa · Cubist Pharms
Zerbaxa works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Zosyn · Merck Sharp & Dohme B.V.
Zosyn works by blocking bacterial enzymes that break down antibiotics, allowing the antibiotics to kill bacteria more effectively.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Bacterial pyelonephritis patent landscape — cliff calendar, originator estates, attackable patents
- Bacterial pyelonephritis treatment landscape brief
- Bacterial pyelonephritis treatment updates RSS
Frequently asked questions about Bacterial pyelonephritis
What drugs treat Bacterial pyelonephritis?
Tracked treatments include Zerbaxa, Zosyn.
What is the treatment for Bacterial pyelonephritis?
Standard treatment for Bacterial pyelonephritis includes Zerbaxa, Zosyn. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Bacterial pyelonephritis patent cliff · Bacterial pyelonephritis CI report
- Treatment: Zerbaxa · Cubist Pharms
- Treatment: Zosyn · Merck Sharp & Dohme B.V.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing